Insulin aspart, recombinant Subcutaneous and Loxapine Succinate
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Loxapine Succinate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: loxapine
Brand name: Loxitane, Adasuve
Synonyms: Loxapine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Loxitane
- Insulin aspart, recombinant Subcutaneous-Lozol
- Insulin aspart, recombinant Subcutaneous-LTA II Kit
- Insulin aspart, recombinant Subcutaneous-Lubiprostone
- Insulin aspart, recombinant Subcutaneous-Lucemyra
- Insulin aspart, recombinant Subcutaneous-Lucentis
- Loxapine Succinate-Insulin degludec
- Loxapine Succinate-Insulin Degludec (U-100) Prefilled Pens
- Loxapine Succinate-Insulin Degludec (U-100) Vials
- Loxapine Succinate-Insulin Degludec (U-200) Prefilled Pens
- Loxapine Succinate-Insulin degludec and liraglutide
- Loxapine Succinate-Insulin degludec and liraglutide Subcutaneous